Cornea۲۰۲۵۲ استنادنمایه شده در PubMed
Samuel H Kim, Rayna F Marshall, Karen M Wai, Ehsan Rahimy, Filippos Vingopoulos, Kapil Mishra, Meghan Berkenstock, Prithvi Mruthyunjaya
چکیده
Ocular adverse events can be black box warning complications for antibody drug conjugates (ADCs), requiring ophthalmologic evaluation. Although extensive management and deescalation protocols are in place, association with overall survival for patients with ocular adverse events are unknown.…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/ico.0000000000003997